Glycemicon AG

Glycemicon AG

Glycemicon AG

Glycemicon AG is a Swiss biotechnology company developing novel nutraceuticals for managing prediabetes, diabetes and obesity.
Raised
$250k
Follow us
Alexa global traffic share
Latest funding
$250,000
Venture capital - 2017
Team Size
1–10
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Glycemicon AG makes some noise.